title: In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
abstract: We evaluated the in vitro activity of fosfomycin against 75 clinical isolates of vancomycin-resistant enterococci (VRE). Using the NCCLS breakpoint for susceptibility of urinary tract isolates to fosfomycin (MIC > or = 256), 51 out of 52 Enterococcus faecium and all Enterococcus faecalis isolates tested were susceptible or intermediate to fosfomycin.
authors: Department of Medicine, Section of Infectious Diseases, William Beaumont Hospital, Royal Oak, MI, USA.
authors: Mary Beth
authors: MB
authors: Perri
authors: Ellie
authors: E
authors: Hershberger
authors: Mihaela
authors: M
authors: Ionescu
authors: Carl
authors: C
authors: Lauter
authors: Marcus J
authors: MJ
authors: Zervos
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D013293:Enterococcus faecalis / Q000187:drug effects* / Q000302:isolation & purification; D016984:Enterococcus faecium / Q000187:drug effects* / Q000302:isolation & purification; D005578:Fosfomycin / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin